Richard Söll

5.0k total citations
75 papers, 2.7k citations indexed

About

Richard Söll is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Richard Söll has authored 75 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Organic Chemistry and 21 papers in Hematology. Recurrent topics in Richard Söll's work include Chronic Myeloid Leukemia Treatments (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chemical Synthesis and Analysis (10 papers). Richard Söll is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Chemical Synthesis and Analysis (10 papers). Richard Söll collaborates with scholars based in United States, Germany and China. Richard Söll's co-authors include John Doukas, Glenn Noronha, John Hood, David A. Cheresh, Michael Martin, Sara M. Weis, Annette G. Beck‐Sickinger, Chi Ching Mak, Ayalew Tefferi and Malcolm R. Wood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Richard Söll

73 papers receiving 2.6k citations

Peers

Countries citing papers authored by Richard Söll

Since Specialization

Citations

This map shows the geographic impact of Richard Söll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Söll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Söll more than expected).

Fields of papers citing papers by Richard Söll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Söll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Söll. The network helps show where Richard Söll may publish in the future.

Co-authorship network of co-authors of Richard Söll

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Söll. A scholar is included among the top collaborators of Richard Söll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Söll. Richard Söll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibitors of ABL and the ABL-T315I Mutation 2008 ·Current Topics in Medicinal Chemistry ·Glenn Noronha, Jianguo Cao, (unknown), Elena Dneprovskaia, Richard Fine, John Hood, Xinshan Kang, Boris Klebansky, (unknown), C. H. Mak, A. McPherson, Moorthy S. S. Palanki, Ved P. Pathak, (unknown), Richard Söll, (unknown)	34
2	Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors 2008 ·Cancer Cell ·Ifat Geron, Annelie Abrahamsson, Charlene F. Barroga, Edward Kavalerchik, Jason Gotlib, John Hood, Jeffrey A. Durocher, Chi Ching Mak, Glenn Noronha, Richard Söll, Ayalew Tefferi, K Kaushansky, Catriona Jamieson	104
3	Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors 2008 ·Cancer Cell ·Ifat Geron, Annelie Abrahamsson, Charlene F. Barroga, Edward Kavalerchik, Jason Gotlib, John Hood, Jeffrey A. Durocher, Chi Ching Mak, Glenn Noronha, Richard Söll, Ayalew Tefferi, K Kaushansky, Catriona Jamieson	1
4	Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease 2008 ·Journal of Pharmacology and Experimental Therapeutics ·John Doukas, (unknown), Karin J. Stebbins, (unknown), Luis Dellamary, Michael Martin, Elena Dneprovskaia, Glenn Noronha, Richard Söll, Wolfgang Wrasidlo, Lisette M. Acevedo, David A. Cheresh	86
5	A Dual VEGFR/JAK2 Kinase Inhibitor Suitable for Topical Delivery Inhibits Choroid Neovascularization in Mice 2007 ·Investigative Ophthalmology & Visual Science ·(unknown), C. H. Mak, (unknown), Daniel L. Lohse, Luis Dellamary, M. De Martin, John Hood, Glenn Noronha, John Doukas, Richard Söll	1
6	Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase 2007 ·Drug Metabolism and Disposition ·Ahmed Kousba, Richard Söll, Shiyin Yee, Michael Martin	12
7	Metabolism and Pharmacokinetics of a Novel Src Kinase Inhibitor TG100435 ([7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine) and Its Active N-Oxide Metabolite TG100855 ([7-(2,6-Dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolidin-1-yl)-ethoxy]-phenyl}-amine) 2007 ·Drug Metabolism and Disposition ·Steven Hu, Richard Söll, Shiyin Yee, (unknown), Ahmed Kousba, (unknown), (unknown), A. McPherson, (unknown), Jianguo Cao, (unknown), John Hood, John Doukas, Glenn Noronha, Michael Martin	13
8	TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations 2007 ·Leukemia ·Animesh Pardanani, John Hood, Terra L. Lasho, Ross L. Levine, Michael Martin, Glenn Noronha, Christy M. Finke, Chi Ching Mak, Ruben A. Mesa, Huanzhang Zhu, Richard Söll, D. Gary Gilliland, Ayalew Tefferi	196
9	The design and preliminary structure–activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jianguo Cao, Richard Fine, (unknown), John Hood, Xinshan Kang, Boris Klebansky, (unknown), Chi Ching Mak, A. McPherson, Glenn Noronha, Moorthy S. S. Palanki, Ved P. Pathak, (unknown), Richard Söll, (unknown), Hong Zhu	21
10	Phosphoinositide 3-kinase γ/δ inhibition limits infarct size after myocardial ischemia/reperfusion injury 2006 ·Proceedings of the National Academy of Sciences ·John Doukas, Wolfgang Wrasidlo, Glenn Noronha, Elena Dneprovskaia, Richard Fine, Sara M. Weis, John Hood, (unknown), Richard Söll, David A. Cheresh	108
11	Topically Applied Src Kinase/VEGFR Prodrug Reduces Retinal Vascular Permeability 2006 ·Investigative Ophthalmology & Visual Science ·Edith Aguilar, (unknown), Michael I. Dorrell, John Hood, Richard Söll, Shiyin Yee, Martin Friedlander	0
12	Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction 2004 ·Journal of Clinical Investigation ·Sara M. Weis, Satoshi Shintani, Alberto Weber, Rudolf Kirchmair, Malcolm R. Wood, (unknown), (unknown), Atsushi Iwakura, Young‐sup Yoon, Nathan Himes, Deborah Burstein, John Doukas, Richard Söll, Douglas W. Losordo, David A. Cheresh	275
13	Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bruce E. Tomczuk, Tianbao Lu, Richard Söll, (unknown), Aihua Wang, (unknown), Carl Crysler, Malini Dasgupta, Stephen Eisennagel, John Spurlino, Roger Bone	24
14	Design and Synthesis of 4,5-Disubstituted-thiophene-2-amidines as Potent Urokinase Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Rudolph, Carl R. Illig, Nalin L. Subasinghe, Kenneth J. Wilson, (unknown), (unknown), David Green, Christopher J. Molloy, Richard Söll, Frank Lewandowski, Marie Zhang, Roger Bone, John Spurlino, Ingrid C. Deckman, Carl L. Manthey, Celia Sharp, Diane Maguire, Bruce Grasberger, Renée L. DesJarlais, Zhou Zhao	23
15	The SK‐N‐MC cell line expresses an orexin binding site different from recombinant orexin 1‐type receptor 2002 ·European Journal of Biochemistry ·H. Wieland, Richard Söll, Henri Doods, Dirk Stenkamp, (unknown), (unknown), Annette G. Beck‐Sickinger	26
16	A rationally designed oligopeptide shows significant conformational changes upon binding to sulphate ions 2001 ·Biosensors and Bioelectronics ·Caspar Demuth, Oliver Zerbe, Didier Rognan, Richard Söll, Annette G. Beck‐Sickinger, Gerd Folkers, Ursula E. Spichiger	6
17	Novel analogues of neuropeptide Y with a preference for the Y₁‐receptor 2001 ·European Journal of Biochemistry ·Richard Söll, Michaela C. Dinger, Ingrid Lundell, (unknown), Annette G. Beck‐Sickinger	86
18	Solid-phase synthesis of 2,4-diaminoquinazolines 2000 ·Biotechnology and Bioengineering ·Zhendong Wu, (unknown), Richard Söll, (unknown)	2
19	Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Richard Söll, (unknown), Bruce E. Tomczuk, Carl R. Illig, (unknown), Stephen Eisennagel, Roger Bone, (unknown), John Spurlino, F. Raymond Salemme	33
20	In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu, Bruce E. Tomczuk, Carl R. Illig, Roger Bone, (unknown), John Spurlino, F. Raymond Salemme, Richard Söll	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact